Angiopep-2, which binds to LPR1, was conjugated to MMP2-responsive peptides, and used to deliver the Dbait payload, which also acts as a radiosensitiser, specifically to glioma cells in vitro and in vivo via the CPP octa-arginine, enhancing the effects of radiotherapy. Here, MMP2 is linked to glioma.